X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
ABBOTT INDIA LIMITED Fact Sheet - Equitymaster
Investing in India? Get Equitymaster Research  

ABBOTT INDIA LIMITED  (KNOL)


Here is the latest financial fact sheet of Abbott India. For more details, see the Abbott India quarterly results and Abbott India share price and chart. For a sector overview, read our pharmaceuticals sector report.
 
abbott india - 1 Year Stock Price Chart
Loading...

 Price History
    Price Rs 4,575.5       No. of shares m 21.25
    Mkt Cap Rs m 97,229       % ch % -0.8
    Vol '000 0.7       % ch week % 1.5
    P/E X 33.1       % ch 1-mth % 2.1
    P/CF X 35.5       % ch 12-mth % -0.9
    EPS (TTM) Rs 138.2       52 week H/L Rs 5,190.0/4,351.0
(As on Mar 29, 2017 (Close)) »  Best Performing pharmaceuticals Stocks

Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!
 Financials

* Results Consolidated
No. of Months
Year Ending
12
Dec-11
12
Dec-12
15
Mar-14
12
Mar-15
12
Mar-16
5-Yr Chart
Click to enlarge
  EQUITY SHARE DATA
High Rs1,6831,8071,7934,1196,015 
Low Rs1,1781,3751,3003,7003,707 
Sales per share (Unadj.) Rs701.3777.71,080.91,077.31,236.9 
Earnings per share (Unadj.) Rs56.768.193.4107.7122.2 
Diluted earnings per shareRs56.768.193.4107.7122.2 
Cash flow per share (Unadj.) Rs63.777.3103.7114.8129.0 
Dividends per share (Unadj.) Rs17.0017.0023.0031.0035.00 
Adj. dividends per shareRs17.0017.0023.0031.0035.00 
Dividend yield (eoy) %1.21.11.50.80.7 
Book value per share (Unadj.) Rs256.0304.4370.8441.2521.2 
Adj. book value per shareRs256.0304.4370.8441.2521.2 
Shares outstanding (eoy) m21.2521.2521.2521.2521.25 
Bonus/Rights/Conversions  A---- 
Price / Sales ratio x2.02.01.43.63.9 
Avg P/E ratio x25.323.416.636.339.8 
P/CF ratio (eoy) x22.520.614.934.137.7 
Price / Book Value ratio x5.65.24.28.99.3 
Dividend payout %30.025.024.628.828.6 
Avg Mkt Cap Rs m30,39833,80932,85883,079103,296 
No. of employees `0002.42.72.82.93.0 
Total wages/salary Rs m1,6732,0622,9973,0543,370 
Avg. sales/employee Rs Th6,145.26,196.88,304.07,985.18,891.8 
Avg. wages/employee Rs Th689.9773.21,083.71,065.21,140.0 
Avg. net profit/employee Rs Th496.4542.6717.5798.6878.3 
  INCOME DATA
Net Sales Rs m14,90216,52722,96922,89326,284 
Other income Rs m197223482476504 
Total revenues Rs m15,09916,75023,45123,36926,789 
Gross profit Rs m1,7552,0182,6833,1233,665 
Depreciation Rs m150195219149144 
Interest Rs m00158 
Profit before tax Rs m1,8022,0462,9463,4444,017 
Minority Interest Rs m00000 
Prior Period Items Rs m-430000 
Extraordinary Inc (Exp) Rs m0104000 
Tax Rs m5557039611,1541,421 
Profit after tax Rs m1,2041,4471,9852,2902,596 
Gross profit margin %11.812.211.713.613.9 
Effective tax rate %30.834.432.633.535.4 
Net profit margin %8.18.88.610.09.9 
  BALANCE SHEET DATA
Current assets Rs m6,8637,7399,96512,26114,446 
Current liabilities Rs m2,3852,29630,6123,9694,725 
Net working cap to sales %30.032.9-89.936.237.0 
Current ratio x2.93.40.33.13.1 
Inventory Days Days6258576151 
Debtors Days Days3231172120 
Net fixed assets Rs m8001,0929951,0001,113 
Share capital Rs m212213213213213 
"Free" reserves Rs m5,1736,2007,6109,10710,808 
Net worth Rs m5,4416,4697,8799,37511,076 
Long term debt Rs m00000 
Total assets Rs m7,9139,07111,39213,73616,241 
Interest coverage xNM10,231.03,682.9689.7497.0 
Debt to equity ratio x00000 
Sales to assets ratio x1.91.82.01.71.6 
Return on assets %15.216.017.416.716.0 
Return on equity %22.122.425.224.423.4 
Return on capital %32.333.237.436.836.3 
Exports to sales %0.40.70.60.50.6 
Imports to sales %7.910.715.99.912.6 
Exports (fob) Rs m59120141122162 
Imports (cif) Rs m1,1761,7643,6592,2643,322 
Fx inflow Rs m113179240215268 
Fx outflow Rs m1,5172,1174,0412,7373,927 
Net fx Rs m-1,404-1,937-3,801-2,523-3,659 
  CASH FLOW
From Operations Rs m 241 1,014 1,545 2,148 2,514 
From Investments Rs m 51 -585 -1,431 -1,867 -800 
From Financial Activity Rs m -420 -420 -424 -576 -803 
Net Cashflow Rs m -129 8 -309 -295 912 
* Results Consolidated Source: Company Annual Reports, Regulatory Filings, Equitymaster »  Historical quarterly results for abbott india limited

 Share Holding
Indian Promoters : 0.0%
Foreign collaborators : 75.0%
Indian inst/Mut Fund : 7.9%
FIIs : 0.1%
ADR/GDR : 0.0%
Free float : 17.1%
Shareholders : 18,270
Pledged promoter(s) holding : 0.0%
 Company Information
Top
    REGD OFF: 3-4, Corporate Park, Sion Trombay Road, Mumbai - 400 071
    E-MAIL: investor.relations@abbott.co.in     WEB: www.abbott.co.in
    TELEPHONE: (022) 6797 8888     FAX: (022) 6797 8727
    SECTOR: PHARMACEUTICALS     GROUP: M N C
    TR AGENT: Sharepro Serv., 13 AB, Samhita Warehousing, 2nd Flr, Andheri (E), Mumbai-72
    AUDITOR: Deloitte Haskins & Sells
CHM: Munir Shaikh COMP SEC: Krupa Anandpara YEAR OF INC: 1944 BSE CODE: 500488 FV (Rs): 10 DIV YIELD (%): 0.8

More pharmaceuticals Company Fact Sheets:   AMAR REMEDIESWYETH LTDSANOFI INDIACADILA HEALTHCAREWOCKHARDT LTD.


Today's Market

Sensex Finishes Firm; Automobile Stocks Fall on SC Verdict(Closing)

Indian share markets finished the trading day on a positive note. At the closing bell, the BSE Sensex closed higher by 122 points, whereas the NSE Nifty finished higher by 43 points.

Views on news

Sun Pharma: Slow Growth Across Major Markets (Quarterly Results Update - Detailed)

Mar 11, 2017

Sun Pharma has announced its December quarter (3QFY17) results. The company has reported 8% YoY growth in sales and a decline of 4.7% YoY in the net profits.

Cipla: Operating Margins Improve (Quarterly Results Update - Detailed)

Mar 8, 2017

Cipla has announced its results for the December quarter (1QFY17) results. The company has reported a decline of 6.4% YoY in sales while profits were down by 43.7% YoY.

Lupin: US Business Drives Growth (Quarterly Results Update - Detailed)

Mar 8, 2017

Lupin has announced its 3QFY17 results. Net sales have grown by 31.5% YoY and net profits have surged by 20.7% YoY. Here is our analysis of the results.

Glenmark: Zetia Generics Boost Growth (Quarterly Results Update - Detailed)

Feb 15, 2017

Glenmark has announced its 3QFY16 results. The company has reported 41% YoY growth in net sales and 143.2% YoY increase in net profits. Here is our analysis of the results.

Sun Pharma: USFDA Observations Post Good Quarterly Performance (Quarterly Results Update - Detailed)

Dec 12, 2016

Sun Pharma has announced its September quarter (2QFY17) results. The company has reported 13.2% YoY growth in sales and a growth of 117% in the net profits. Here is our analysis of the results.

More Views on News

Most Popular

Bluechips Have 60% Chance Of Losing Money At Current Levels. But a Small Group Won't...(The 5 Minute Wrapup)

Mar 17, 2017

The trend that makes a select group of bluechip stocks inherently safer even at peak index valuations.

Doubled Your Money In D-Mart? Read This Before It's Too Late(Daily Profit Hunter)

Mar 22, 2017

Apurva breaks down the historic performance of initial public offerings in the context of D-Mart.

As Digital Transactions Fall, Indians Are Going Back to Cash(Vivek Kaul's Diary)

Mar 16, 2017

Digital transactions have fallen since December 2016 both in value and volume terms.

Stock Markets and Gold Rally, Dollar Tumbles(Chart Of The Day)

Mar 16, 2017

Markets are moving up even after the fed interest rate hike.

Why Mutual Fund Investors Should Not Worry About Market High. But...(Outside View)

Mar 22, 2017

PersonalFN provides a prudent investment strategy to invest in mutual funds as market scales a new high.

More

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ABBOTT INDIA

ABBOTT INDIA - PFIZER COMPARISON

Compare Company With Charts

COMPARE ABBOTT INDIA WITH

MARKET STATS